United States · FDA National Drug Code directory

EVEROLIMUS

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 60219-2279_0e3290d2-c865-446d-935b-290ce331789a
Product NDC: 60219-2279
Form: TABLET, FOR SUSPENSION
Composition / generic term: everolimus
Labeler: Amneal Pharmaceuticals NY LLC
Marketing category: ANDA
Marketing start / end (source format): 20250114
Source listing expiry: 20271231

Source-listed ingredients

EVEROLIMUS — 2 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

4 BLISTER PACK in 1 CARTON (60219-2279-2) / 7 TABLET, FOR SUSPENSION in 1 BLISTER PACK (60219-2279-1) · 60219-2279-2

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →